TherapeuticsMD, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - August 9, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - TherapeuticsMD, Inc.Financial_Report.xls
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex-31_2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.ex-31_1.htm
EX-10.27 - CONSULTING AGREEMENT WITH SANCILIO AND COMPANY, INC. - TherapeuticsMD, Inc.ex-10_27.htm
EX-10.26 - MASTER SERVICES AGREEMENT WITH SANCILIO AND COMPANY, INC - TherapeuticsMD, Inc.ex-10_26.htm
10-Q - QUARTERLY REPORT - TherapeuticsMD, Inc.txmd-10q_063012.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex-32_2.htm
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of TherapeuticsMD, Inc. (the "Company") on Form 10-Q for the period ended June 30, 2012 as filed with the Securities and Exchange Commission (the "Report"), I, Robert G. Finizio, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Robert G. Finizio
Robert G. Finizio
Chief Executive Officer
August 9, 2012

A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
 
 

TherapeuticsMD, Inc. Reports